mRNA Therapeutics Beyond Vaccines: Delivery, Redosing and Durability of Protein Replacement
DOI:
https://doi.org/10.5281/zenodo.22649259Keywords:
mRNA Therapeutics Beyond Vaccines; Translational medicine;, Evidence synthesis; Clinical implementation, Health services researchAbstract
mRNA Therapeutics Beyond Vaccines is an area of active development in translational medicine, with evidence that has
accumulated unevenly across its component questions. We review the current evidence base for mrna therapeutics beyond
vaccines, spanning analytical, clinical, implementation, governance, and economic dimensions, focusing on where practice has
converged and where it continues to vary, and set out the practical considerations relevant to a service considering its adoption.
We conclude that selective, context-specific use is best supported by the evidence currently available, rather than uniform
adoption or avoidance.
References
Alvez D, Dumitrescu A, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". J Transl Med 8(2011): 80-86. DOI: 10.7759/cureus.104086
Brankovic K, Kowalczyk B, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". Clin Pharmacol Ther 10(2014): 91-98. DOI: 10.1038/s41746-023-00852-5
Castellani R, Ristic C, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". Nat Rev Drug Discov 12(2017): 102-110. DOI: 10.1016/j.mayocpiqo.2022.09.004
Dumitrescu A, Andric D, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". Trials 14(2020): 113-122. DOI: 10.1177/08404704241291226
Eriksdottir B, Brankovic E, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". Drug Discov Today 16(2023): 124-134. DOI: 10.1093/medlaw/fwad013 7
Farkas I, Ionescu F, et al. "mRNA Therapeutics Beyond Vaccines: a consensus statement". Clin Cancer Res 18(2011): 135-146. DOI: 10.2196/89834
Grabowski P, Petrescu G, et al. "mRNA Therapeutics Beyond Vaccines: a retrospective analysis". BMJ Open 20(2014): 146-158. DOI: 10.1007/s10916-024-02104-9
Hendriksen W, Wojcik H, et al. "mRNA Therapeutics Beyond Vaccines: a validation study". J Clin Epidemiol 22(2017): 157-170. DOI: 10.3389/fdgth.2026.1896184
Ionescu F, Foscarini I, et al. "mRNA Therapeutics Beyond Vaccines: a scoping review". Contemp Clin Trials 24(2020): 168-182. DOI:
3390/diagnostics15162117 10. Jankowiak G, Grabowski J, et al. "mRNA Therapeutics Beyond Vaccines: a health-economic analysis". Ther Innov Regul Sci 26(2023): 179-185. DOI: 10.4103/jrpp.jrpp_20_65
Kowalczyk N, Novotna K, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". Br J Clin Pharmacol 28(2011): 190-197. DOI: 10.3389/fdgth.2026.1763884
Lindqvist U, Urbanek L, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". PLoS Med 30(2014): 201-209. DOI: 10.2196/48297
Marchetti D, Doncheva M, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". Lancet 32(2017): 212-221. DOI: 10.1007/s00330-025-12031-z
Novotna E, Eriksdottir N, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". N Engl J Med 34(2020): 223-233. DOI: 10.3389/fdgth.2026.1699005
Ostrowski L, Lindqvist O, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". JAMA 36(2023): 234-245. DOI: 10.3389/fdgth.2026.1834800
Petrescu S, Szabo P, et al. "mRNA Therapeutics Beyond Vaccines: a consensus statement". Nat Med 38(2011): 245-257. DOI: 10.2196/69678
Quintero B, Balogh Q, et al. "mRNA Therapeutics Beyond Vaccines: a retrospective analysis". Cell Rep Med 40(2014): 256-269. DOI: 10.7759/cureus.46454
Ristic C, Castellani R, et al. "mRNA Therapeutics Beyond Vaccines: a validation study". Clin Transl Sci 42(2017): 267-281. DOI: 10.1016/j.ssci.2025.107028
Szabo J, Jankowiak S, et al. "mRNA Therapeutics Beyond Vaccines: a scoping review". Pharmacogenomics J 44(2020): 278-284. DOI: 10.2196/48633
Tarasov Q, Quintero T, et al. "mRNA Therapeutics Beyond Vaccines: a health-economic analysis". Regul Toxicol Pharmacol 46(2023): 289-296. DOI: 10.1371/journal.pone.0305949
Urbanek Z, Zielinski U, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". Drug Saf 8(2011): 300-308. DOI: 10.1371/journal.pdig.0000514
Vasquez A, Alvez V, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". Ann Intern Med 10(2014): 311-320. DOI: 10.17219/acem/208596
Wojcik H, Hendriksen W, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". BMC Med 12(2017): 322-332. DOI: 10.7759/cureus.104086
Zielinski O, Ostrowski Z, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". Sci Transl Med 14(2020): 333-344. DOI: 10.1038/s41746-023-00852-5
Andric V, Vasquez A, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". J Transl Med 16(2023): 344-356. DOI: 10.1016/j.mayocpiqo.2022.09.004
Balogh E, Emmerich B, et al. "mRNA Therapeutics Beyond Vaccines: a consensus statement". Clin Pharmacol Ther 18(2011): 355-368. DOI: 10.1177/08404704241291226
Chiriac F, Farkas C, et al. "mRNA Therapeutics Beyond Vaccines: a retrospective analysis". Nat Rev Drug Discov 20(2014): 366-380. DOI: 10.1093/medlaw/fwad013
Doncheva M, Marchetti D, et al. "mRNA Therapeutics Beyond Vaccines: a validation study". Trials 22(2017): 377-383. DOI: 10.2196/89834
Emmerich T, Tarasov E, et al. "mRNA Therapeutics Beyond Vaccines: a scoping review". Drug Discov Today 24(2020): 388-395. DOI: 10.1007/s10916-024-02104-9
Foscarini C, Chiriac F, et al. "mRNA Therapeutics Beyond Vaccines: a health-economic analysis". Clin Cancer Res 26(2023): 399-407. DOI: 10.3389/fdgth.2026.1896184
Alvez D, Dumitrescu A, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". BMJ Open 28(2011): 410-419. DOI: 10.3390/diagnostics15162117
Brankovic K, Kowalczyk B, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". J Clin Epidemiol 30(2014): 421-431. DOI: 10.4103/jrpp.jrpp_20_65
Castellani R, Ristic C, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". Contemp Clin Trials 32(2017): 432-443. DOI: 10.3389/fdgth.2026.1763884
Dumitrescu A, Andric D, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". Ther Innov Regul Sci 34(2020): 443-455. DOI: 10.2196/48297
Eriksdottir B, Brankovic E, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". Br J Clin Pharmacol 36(2023): 454-467. DOI: 10.1007/s00330-025-12031-z
Farkas I, Ionescu F, et al. "mRNA Therapeutics Beyond Vaccines: a consensus statement". PLoS Med 38(2011): 465-479. DOI: 10.3389/fdgth.2026.1699005
Grabowski P, Petrescu G, et al. "mRNA Therapeutics Beyond Vaccines: a retrospective analysis". Lancet 40(2014): 476-482. DOI: 10.3389/fdgth.2026.1834800
Hendriksen W, Wojcik H, et al. "mRNA Therapeutics Beyond Vaccines: a validation study". N Engl J Med 42(2017): 487-494. DOI: 10.2196/69678
Ionescu F, Foscarini I, et al. "mRNA Therapeutics Beyond Vaccines: a scoping review". JAMA 44(2020): 498-506. DOI: 10.7759/cureus.46454
Jankowiak G, Grabowski J, et al. "mRNA Therapeutics Beyond Vaccines: a health-economic analysis". Nat Med 46(2023): 509-518. DOI: 10.1016/j.ssci.2025.107028
Kowalczyk N, Novotna K, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". Cell Rep Med 8(2011): 520-530. DOI: 10.2196/48633
Lindqvist U, Urbanek L, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". Clin Transl Sci 10(2014): 531-542. DOI: 10.1371/journal.pone.0305949
Marchetti D, Doncheva M, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". Pharmacogenomics J 12(2017): 542-554. DOI: 10.1371/journal.pdig.0000514
Novotna E, Eriksdottir N, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". Regul Toxicol Pharmacol 14(2020): 553-566. DOI: 10.17219/acem/208596
Ostrowski L, Lindqvist O, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". Drug Saf 16(2023): 564-578. DOI: 10.7759/cureus.104086
Petrescu S, Szabo P, et al. "mRNA Therapeutics Beyond Vaccines: a consensus statement". Ann Intern Med 18(2011): 575-581. DOI: 10.1038/s41746-023-00852-5
Quintero B, Balogh Q, et al. "mRNA Therapeutics Beyond Vaccines: a retrospective analysis". BMC Med 20(2014): 586-593. DOI: 10.1016/j.mayocpiqo.2022.09.004
Ristic C, Castellani R, et al. "mRNA Therapeutics Beyond Vaccines: a validation study". Sci Transl Med 22(2017): 597-605. DOI: 10.1177/08404704241291226
Szabo J, Jankowiak S, et al. "mRNA Therapeutics Beyond Vaccines: a scoping review". J Transl Med 24(2020): 608-617. DOI: 10.1093/medlaw/fwad013
Tarasov Q, Quintero T, et al. "mRNA Therapeutics Beyond Vaccines: a health-economic analysis". Clin Pharmacol Ther 26(2023): 619-629. DOI: 10.2196/89834
Urbanek Z, Zielinski U, et al. "mRNA Therapeutics Beyond Vaccines: a systematic review". Nat Rev Drug Discov 28(2011): 630-641. DOI: 10.1007/s10916-024-02104-9
Vasquez A, Alvez V, et al. "mRNA Therapeutics Beyond Vaccines: a methodological appraisal". Trials 30(2014): 641-653. DOI: 10.3389/fdgth.2026.1896184
Wojcik H, Hendriksen W, et al. "mRNA Therapeutics Beyond Vaccines: a multicentre analysis". Drug Discov Today 32(2017): 652-665. DOI: 10.3390/diagnostics15162117
Zielinski O, Ostrowski Z, et al. "mRNA Therapeutics Beyond Vaccines: a prospective cohort study". Clin Cancer Res 34(2020): 663-677. DOI: 10.4103/jrpp.jrpp_20_65
Andric V, Vasquez A, et al. "mRNA Therapeutics Beyond Vaccines: a randomised evaluation". BMJ Open 36(2023): 674-680. DOI: 10.3389/fdgth.2026.1763884
